VAPO
Vapotherm, Inc.
Set alert
52-week range unavailable
- Open
- 2.17
- Prev close
- 2.17
- Mkt cap
- 6.94M
- Vol
- 28.04K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.17
- High
- 2.17
- Forward P/E
- -0.39
- Beta
- -1.19
- Short ratio
- 12.93
- Inst. own
- 48.13%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 25, 2024
- 50-d avg
- 2.00
- 200-d avg
- 3.28
- 1y target
- 1.00
Key statistics
- Market cap
- 6.94M
- Enterprise value
- 102.82M
- Trailing P/E
- 0.00
- Forward P/E
- -0.39
- PEG ratio
- -0.01
- Price / sales
- 0.10
- Price / book
- 0.00
- EPS (TTM)
- -14.33
- Beta
- -1.19
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -102.73%
- Revenue (TTM)
- 67.60M
- Revenue growth
- 12.00%
- Free cash flow
- -21.57M
- Total cash
- 14.42M
- Total debt
- 111.10M
- Return on equity
- 0.00%
- Shares outstanding
- 6.14M
- Short % of float
- 10.20%
- 50-day average
- 2.00
- 200-day average
- 3.28
Analyst view
Consensus: hold
- Strong buy4
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Dec 25, 2024
Expected Dec 25, 2024. Consensus EPS estimate -1.63.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 25, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.00 | -1.76 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -2.31 | — | — |
| Feb 22, 2024 | Dec 1, 2023 | 0.00 | -1.60 | — | — |
| Nov 8, 2023 | Sep 1, 2023 | -2.20 | -2.26 | -0.06 | -2.73% |
| Aug 8, 2023 | Jun 1, 2023 | -3.04 | -2.32 | +0.72 | +23.68% |
About Vapotherm, Inc.
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- vapotherm.com
News
- Vapotherm Announces Closing of Merger
- Vapotherm Reports Second Quarter 2024 Financial Results
- SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. - VAPO
- SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. – VAPO
- The Schall Law Firm Is Performing A Scrutiny Into Vapotherm Inc And Welcomes Investors Of VAPO To Engage
- The Schall Law Firm Is Carrying Out An Inquiry Into Vapotherm Inc And Requests Investors Of VAPO To Be Part Of It
- The Schall Law Firm Is Undertaking An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To Join
- The Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To Join
- The Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages VAPO Investors To Participate
- The Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages Investors Of VAPO To Participate
Your note
Sign in to keep a note on VAPO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARMY JOSEPH F | Chief Executive Officer | Purchase | Sep 7, 2023 | 432,783 |
| ARNERICH ANTHONY L | Director | Stock Award(Grant) | Dec 28, 2023 | 214,618 |
| BERRY LANCE A | Director | Stock Award(Grant) | Jul 25, 2023 | 155,887 |
| KNOWLES LORI LYNN | Director | Stock Award(Grant) | Dec 28, 2023 | 10,237 |
| LANDRY JOHN | Chief Financial Officer | Stock Award(Grant) | Oct 1, 2023 | 70,411 |
| LAWRENCE BRIAN | Chief Technology Officer | Stock Award(Grant) | Oct 1, 2023 | 60,188 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Crow's Nest Holdings LP | 1.14% | 561,002 | 2.00M | Jun 29, 2023 |
| Armistice Capital, LLC | 0.96% | 471,250 | 1.68M | Jun 29, 2023 |
| Millennium Management Llc | 0.72% | 354,355 | 1.26M | Jun 29, 2023 |
| Taylor Frigon Capital Management LLC | 0.57% | 279,896 | 996.43K | Jun 29, 2023 |
| Vanguard Group Inc | 0.32% | 154,656 | 550.58K | Jun 29, 2023 |
| Tejara Capital Ltd | 0.22% | 107,467 | 382.58K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.22% | 110,297 | 392.66K | Jun 29, 2023 |
| PFS Funds-Taylor Frigon Core Growth Fund | 0.10% | 49,359 | 156.96K | Aug 30, 2023 |
| Vanguard Extended Market Index Fund | 0.08% | 39,848 | 141.86K | Jun 29, 2023 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.04% | 18,688 | 66.53K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.03% | 14,858 | 72.51K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.01% | 3,870 | 18.89K | May 30, 2023 |